Related references
Note: Only part of the references are listed.Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype
Konrad Gabrusiewicz et al.
JCI INSIGHT (2016)
Structural and functional features of central nervous system lymphatic vessels
Antoine Louveau et al.
NATURE (2015)
Revisiting the Mechanisms of CNS Immune Privilege
Antoine Louyeau et al.
TRENDS IN IMMUNOLOGY (2015)
Effect of NKG2D ligand expression on host immune responses
Marine Champsaur et al.
IMMUNOLOGICAL REVIEWS (2015)
Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2015)
Immunopathology of multiple sclerosis
Calliope A. Dendrou et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Immunotherapy for Primary Brain Tumors: No Longer a Matter of Privilege
Peter E. Fecci et al.
CLINICAL CANCER RESEARCH (2014)
Increased frequencies of CD11b+CD33+CD14+HLA-DRlow myeloid-derived suppressor cells are an early event in melanoma patients
Berenice M. Rudolph et al.
EXPERIMENTAL DERMATOLOGY (2014)
Of snowflakes and natural killer cell subsets
Lewis L. Lanier
NATURE BIOTECHNOLOGY (2014)
Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients
Courtney A. Crane et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The Genetic Signatures of Pediatric High-Grade Glioma: No Longer a One-Act Play
Alexander K. Diaz et al.
SEMINARS IN RADIATION ONCOLOGY (2014)
MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape
Paula Codo et al.
ONCOTARGET (2014)
Immunotherapeutic implications of the immunophenotype of pediatric brain tumors
Andrea M. Griesinger et al.
ONCOIMMUNOLOGY (2014)
Tumor-Derived Lactate Modifies Antitumor Immune Response: Effect on Myeloid-Derived Suppressor Cells and NK Cells
Zaheed Husain et al.
JOURNAL OF IMMUNOLOGY (2013)
Targeting developmental pathways in children with cancer: what price success?
Lia Gore et al.
LANCET ONCOLOGY (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Functional significance of CD57 expression on human NK cells and relevance to disease
Carolyn M. Nielsen et al.
FRONTIERS IN IMMUNOLOGY (2013)
Tumour-infiltrating T-cell subpopulations in glioblastomas
Young-Hee Kim et al.
BRITISH JOURNAL OF NEUROSURGERY (2012)
Innate immunity in the central nervous system
Richard M. Ransohoff et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The incidence of medulloblastomas and primitive neurectodermal tumours in adults and children
Nicolas R. Smoll et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2012)
Increased Immune Gene Expression and Immune Cell Infiltration in High-Grade Astrocytoma Distinguish Long-Term from Short-Term Survivors
Andrew M. Donson et al.
JOURNAL OF IMMUNOLOGY (2012)
Paediatric and adult malignant glioma: close relatives or distant cousins?
Chris Jones et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Pediatric high grade glioma: a review and update on tumor clinical characteristics and biology
Jason Fangusaro
FRONTIERS IN ONCOLOGY (2012)
Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment
Christopher Jackson et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2011)
CD56brightCD16+ NK Cells: A Functional Intermediate Stage of NK Cell Differentiation
Vivien Beziat et al.
JOURNAL OF IMMUNOLOGY (2011)
Incidence of Atypical Teratoid/Rhabdoid Tumors in Children A Population-Based Study by the Austrian Brain Tumor Registry, 1996-2006
Adelheid Woehrer et al.
CANCER (2010)
被撤回的出版物: Glioma-Associated Cancer-Initiating Cells Induce Immunosuppression (Retracted article. See vol. 21, pg. 2189, 2015)
Jun Wei et al.
CLINICAL CANCER RESEARCH (2010)
TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8(+) T cells glioma patients
Courtney A. Crane et al.
NEURO-ONCOLOGY (2010)
Glioblastoma-Derived Mechanisms of Systemic Immunosuppression
Allen Waziri
NEUROSURGERY CLINICS OF NORTH AMERICA (2010)
Brain Tumors Across the Age Spectrum: Biology, Therapy, and Late Effects
Thomas E. Merchant et al.
SEMINARS IN RADIATION ONCOLOGY (2010)
Natural Killer Cell IFN-γ Levels Predict Long-term Survival with Imatinib Mesylate Therapy in Gastrointestinal Stromal Tumor-Bearing Patients
Cedric Menard et al.
CANCER RESEARCH (2009)
Coordination of Intratumoral Immune Reaction and Human Colorectal Cancer Recurrence
Matthieu Camus et al.
CANCER RESEARCH (2009)
NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo
Tadepally Lakshmikanth et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Regulation of innate immune responses in the brain
Serge Rivest
NATURE REVIEWS IMMUNOLOGY (2009)
Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways
Jerome D. Coudert et al.
BLOOD (2008)
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy
Nadia Guerra et al.
IMMUNITY (2008)
Initial Management of Childhood Brain Tumors: Neurosurgical Considerations
Farideh Nejat et al.
JOURNAL OF CHILD NEUROLOGY (2008)
Up on the tightrope: natural killer cell activation and inhibition
Lewis L. Lanier
NATURE IMMUNOLOGY (2008)
Adaptive immunity maintains occult cancer in an equilibrium state
Catherine M. Koebel et al.
NATURE (2007)
NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway
Tiffany Horng et al.
NATURE IMMUNOLOGY (2007)
The combined actions of NK and T lymphocytes are necessary to reject an EGFP plus mesenchymal tumor through mechanisms dependent on NKG2D and IFNγ
Ainhoa Arina et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Cancer immunoediting from immune surveillance to immune escape
Ryungsa Kim et al.
IMMUNOLOGY (2007)
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
Andrew T. Parsa et al.
NATURE MEDICINE (2007)
Interferons, immunity and cancer immunoediting
Gavin P. Dunn et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial
Amar Gajjar et al.
LANCET ONCOLOGY (2006)
Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma
Roger J. Packer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Release of MICB molecules by tumor cells: Mechanism and soluble MICB in sera of cancer patients
Helmut Rainer Salih et al.
HUMAN IMMUNOLOGY (2006)
CD4+-CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer
MJ Smyth et al.
JOURNAL OF IMMUNOLOGY (2006)
Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host
B Huang et al.
CANCER RESEARCH (2006)
Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells
JD Coudert et al.
BLOOD (2005)
Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors
P André et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
The immunobiology of cancer immunosurveillance and immunoediting
GP Dunn et al.
IMMUNITY (2004)
NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway
DD Billadeau et al.
NATURE IMMUNOLOGY (2003)
Natural killer cell receptor signaling
LL Lanier
CURRENT OPINION IN IMMUNOLOGY (2003)
A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma
C Burkhard et al.
JOURNAL OF NEUROSURGERY (2003)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
Phenotype, localization, and mechanism of suppression of CD4+CD25+ human thymocytes
F Annunziato et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Cutting edge:: Control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells
CA Piccirillo et al.
JOURNAL OF IMMUNOLOGY (2001)
ULBPs, novel MHC class I-related molecules bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor
D Cosman et al.
IMMUNITY (2001)
Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population
K Imai et al.
LANCET (2000)
Share Paper
